CDH13 and colorectal carcinoma: Brock et al identified the methylation of p16 and CDH13 in tumorous and mediastinal lymph nodes, estimating the odds ratios (ORs) for CRC recurrence as 8.00 (95% CI, 2.50–25.51) and 4.32 (95% CI, 1.61–185.02), respectively.